Stocks Deepen Losses as Treasury Yields Soar

Both the 2-year and 10-year Treasury notes hit multi-year highs

Digital Content Manager
Sep 20, 2022 at 11:59 AM
facebook twitter linkedin


The Dow Jones Industrial Average (DJI) is deepening this morning's losses, down nearly 320 points at last check, as the Federal Open Market Committee's (FOMC) two-day policy meeting gets underway. The S&P 500 Index (SPX) and the Nasdaq Composite (IXIC) are firmly lower as well, with the 2-year and 10-year Treasury yields surging to their highest levels since 2007 and 2011, respectively. Investors are worried the central bank will double down on its hawkish stance, though most already expect a 0.75 basis point interest rate hike.

Continue reading for more on today's market, including:

  • Tailwinds are blowing for this luxury cruise stock.
  • Nike stock skids lower after pre-earnings bear note.
  • Plus, LAZR options running red-hot; IMPX eyes best day ever; and Annovis stock looks to extend losing streak.

MMC Stats 0920

Luminar Technologies Inc (NASDAQ:LAZR) is getting blasted in the options pits, with 45,000 calls and 33,000 puts exchanged so far, which is nine times the average intraday volume. The two most popular contracts are the weekly 9/30 10-strike call and the weekly 9/23 9-strike put, with positions being opened at both. LAZR is up 4.8% at $9.55 at last glance, after J.P. Morgan Securities initiated coverage of the equity with an "overweight" rating and $30 price target. The shares are struggling still with pressure at the $10 level, though, despite support at their 40-day moving average. Year-to-date, LAZR is down 42.5%.

LAZR 40 Day

Near the top of the New York Stock Exchange (NYSE) today is AEA-Bridges Impact Corp(NYSE:IMPX), last seen up 11.1% at $11. A driver for today's positive price action remains unclear, though the security earlier surged to an all-time high of $12.27, just days after bouncing off its Sept. 13, record low of $9.14. Shares are today eyeing their fourth win in five sessions, as well as their best single-day percentage jump since the stock began trading publicly in January.

Conversely, Annovis Bio Inc (NYSE: ANVS) is towards the bottom of the NYSE. Last seen down 10% at $16.80, the company last week announced the publication of patents covering amyloid lateral sclerosis, Huntington's disease, and Prion disease treatments. Shares seem to be cooling from a Sept. 15 rally north of the $23 mark, which marked the security's highest peak since December, and are now eyeing a third-straight daily loss.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners